Efficacy of recainam, a new antiarrhythmic drug, for control of ventricular arrhythmias
- 1 August 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 60 (4) , 281-287
- https://doi.org/10.1016/0002-9149(87)90228-1
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Recainam, A potent new antiarrhythmic agent: Effects on complex ventricular arrhythmiasJournal of the American College of Cardiology, 1986
- Analysis of the spontaneous variability of ventricular arrhythmias: Consecutive ambulatory electrocardiographic recordings of ventricular tachycardiaThe American Journal of Cardiology, 1985
- Risk factors for sudden death after acute myocardial infarction: Two-year follow-upThe American Journal of Cardiology, 1984
- Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogramThe American Journal of Cardiology, 1984
- Definition of benign versus malignant ventricular arrhythmias: Targets for treatmentThe American Journal of Cardiology, 1983
- Oral Flecainide Acetate for the Treatment of Ventricular ArrhythmiasNew England Journal of Medicine, 1981
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980
- Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction.Circulation, 1979
- Antiarrhythmic DrugsDrugs, 1978
- Ventricular Premature Beats and Mortality after Myocardial InfarctionNew England Journal of Medicine, 1977